Vimarsana
Biggest News Aggregation in the World

Page 3 - Mochida News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mochida. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mochida Today - Breaking & Trending Today

Idorsia sells its Asia Pacific (ex-China) operations – - Vimarsana News

Idorsia sells its Asia Pacific (ex-China) operations –

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 20, 2023 Idorsia Ltd (SIX: IDIA) today announced the sale of its operating...

Sosei Heptares Acquires Idorsia's Pharmaceuticals Business - Vimarsana News

Sosei Heptares Acquires Idorsia's Pharmaceuticals Business

Transaction adds complementary late-stage clinical development capability with profitable and fast-growing commercial operations in JapanLean, go-to-market...

Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the first quarter 2023 - QUVIVIQ now the leading branded insomnia medicine in the commercial market in the US - Vimarsana News

Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the first quarter 2023 - QUVIVIQ now the leading branded insomnia medicine in the commercial market in the US

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - April 25, 2023 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2023. Commercial highlights QUVIVIQ

Adjuvant chemotherapy extends survival in pancreatic cancer - Vimarsana News

Adjuvant chemotherapy extends survival in pancreatic cancer

Adjuvant chemotherapy appeared associated with a significant survival benefit among patients with pancreatic ductal adenocarcinoma who underwent multiagent neoadjuvant chemotherapy and resection, according to study results.Investigators observed the survival benefit regardless patients lymph node status or resection margins.

Source: healio.com
Insomnia Market to Observe Growth at a Paltry CAGR of 3.7% During the Study Period (2019-2032), Assesses DelveInsight - Vimarsana News

Insomnia Market to Observe Growth at a Paltry CAGR of 3.7% During the Study Period (2019-2032), Assesses DelveInsight

/PRNewswire/ -- DelveInsight's Insomnia Market Insights report includes a comprehensive understanding of current treatment practices, insomnia emerging drugs,...